|
Volumn 62, Issue 2, 2002, Pages 567-574
|
SEL1L expression decreases breast tumor cell aggressiveness in vivo and in vitro
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AGAR;
COMPLEMENTARY DNA;
LAMININ;
MATRIGEL;
PROTEIN ANTIBODY;
PROTEIN SEL1L;
TUMOR PROTEIN;
UNCLASSIFIED DRUG;
ARTICLE;
BREAST CARCINOMA;
BREAST EPITHELIUM;
CAENORHABDITIS ELEGANS;
CANCER GROWTH;
CANCER INVASION;
CANCER SURVIVAL;
CELL STRAIN MCF 7;
COLONY FORMATION;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DNA TRANSFECTION;
DOWN REGULATION;
EXTRACELLULAR MATRIX;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IN VITRO STUDY;
IN VIVO STUDY;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
PROGNOSIS;
PROMOTER REGION;
PROTEIN EXPRESSION;
BLOTTING, SOUTHERN;
BREAST NEOPLASMS;
CARCINOMA, DUCTAL, BREAST;
CARCINOMA, LOBULAR;
CELL ADHESION;
CELL DIVISION;
DEXAMETHASONE;
FLOW CYTOMETRY;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
POLYMERASE CHAIN REACTION;
PROGNOSIS;
PROTEIN BIOSYNTHESIS;
PROTEINS;
TRANSCRIPTION, GENETIC;
TRANSFECTION;
TUMOR CELLS, CULTURED;
|
EID: 0037081182
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (41)
|
References (26)
|